Soricimed Biopharma Inc.
Records under this name other than the patents Soricimed Biopharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.
Showing 1 to 8 of 8 · Back to Soricimed Biopharma Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,745,588 | Antibodies to a Paralytic Peptide Term ended Term ended Mar 2, 2024 · High confidence | Term ended | Term ended Mar 2, 2024 | High confidence |
| US 7,485,622 | Paralytic Peptide for Use in Neuromuscular Therapy Term ended Term ended Jan 1, 2024 · High confidence | Term ended | Term ended Jan 1, 2024 | High confidence |
| US 7,119,168 | Paralytic Peptide for Use in Neuromuscular Therapy Term ended Term ended Nov 18, 2023 · High confidence | Term ended | Term ended Nov 18, 2023 | High confidence |
| US 7,273,850 | Paralytic Peptide for Use in Neuromuscular Therapy Term ended Term ended Nov 18, 2023 · High confidence | Term ended | Term ended Nov 18, 2023 | High confidence |
| US 8,003,754 | Paralytic Peptide for Use as a Insecticide Term ended Term ended Nov 18, 2023 · High confidence | Term ended | Term ended Nov 18, 2023 | High confidence |
| US 8,338,136 | Method of Producing a Paralytic Peptide No holder on record Term ended Term ended Nov 18, 2023 · High confidence | Term ended | Term ended Nov 18, 2023 | High confidence |
| US 8,673,858 | A Method for Treating Wrinkles Using a Paralytic Peptide from the Shrew Blarina Brevicauda Term ended Term ended Nov 18, 2023 · High confidence | Term ended | Term ended Nov 18, 2023 | High confidence |
| US 8,962,817 | Vectors encoding a paralytic peptide Term ended Term ended Nov 18, 2023 · High confidence | Term ended | Term ended Nov 18, 2023 | High confidence |